Separate · GHK-Cu by injection

An injection calls for its own evidence

Ask for the human evidence for the proposed form, not a borrowed skin claim.

The evidence, the concern and your question

A ClinicalTrials.gov search on September 30, 2026 found no trial testing GHK-Cu injections in people.

ClinicalTrials.gov is a register of studies; that search does not establish that no study exists anywhere.

Ask for any claimed human injection study by name. Check the form, the people enrolled and the result being discussed.

The FDA information used here was checked September 30, 2026 and warns that GHK-Cu injections could cause an immune reaction.

That means the body’s defence system may react against the material.

FDA’s concerns include peptide material sticking together in clumps and unwanted material related to the peptide.

It also says information about safety in people is limited.

Those are stated concerns, rather than a count of confirmed reactions.

Ask why the proposed injection is being considered for your concern. Ask what an assessment could reveal that would change that proposal.

Request the limits of the evidence in the same conversation as the hoped-for benefit.

Ask for evidence that matches the proposed injection and the claimed result.